MACK Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 30.57%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Merrimack Pharmaceuticals Share Price & Price History
Current Price: $15.13
Price Change: +0.30 (1.20%)
As of 05/28/2024 01:00 AM ET
Merrimack Pharmaceuticals Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 12/28/2023 | Eric Andersen | Director | Buy | 857 | $13.35 | $11,440.95 | 534,008 | |
| 12/26/2023 | Eric Andersen | Director | Buy | 48,693 | $13.15 | $640,312.95 | 533,151 | |
| 12/7/2023 | Eric Andersen | Director | Buy | 101,050 | $12.85 | $1,298,492.50 | 1,735,600 | |
| 11/17/2023 | Eric Andersen | Director | Buy | 300 | $12.50 | $3,750.00 | 1,659,216 | |
| 11/14/2023 | Eric Andersen | Director | Buy | 50,170 | $12.50 | $627,125.00 | 1,658,981 | |
| 8/10/2023 | Gary L. Crocker | Insider | Buy | 2,000 | $12.52 | $25,040.00 | 133,105 | |
| 8/7/2023 | Eric Andersen | Director | Buy | 134,493 | $12.00 | $1,613,916.00 | 1,496,680 | |
| 3/21/2023 | Eric Andersen | Director | Buy | 160,590 | $11.52 | $1,849,996.80 | 1,412,044 | |
Merrimack Pharmaceuticals Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 1/16/2025 | MassMutual Private Wealth & Trust FSB | 24,500 | $0.37M | 0.0% | N/A | 0.166% |  |
| 8/14/2024 | Marshall Wace LLP | 38,221 | $0.58M | 0.0% | N/A | 0.258% |  |
| 8/9/2024 | Dimensional Fund Advisors LP | 318,995 | $4.83M | 0.0% | -19.9% | 2.157% |  |
| 8/8/2024 | JBF Capital Inc. | 39,637 | $0.60M | 0.1% | N/A | 0.268% |  |
| 8/1/2024 | Rhumbline Advisers | 2,480 | $38K | 0.0% | -81.7% | 0.017% |  |
| 5/15/2024 | Aristides Capital LLC | 10,000 | $0.15M | 0.1% | N/A | 0.069% |  |
| 5/10/2024 | Vanguard Group Inc. | 620,847 | $9.17M | 0.0% | +2.0% | 4.272% |  |
| 5/1/2024 | BNP Paribas Financial Markets | 5,077 | $75K | 0.0% | +67.3% | 0.035% |  |
| 2/14/2024 | ADAR1 Capital Management LLC | 549,418 | $7.37M | 2.6% | N/A | 3.837% |  |
| 1/30/2024 | Strs Ohio | 3,300 | $44K | 0.0% | N/A | 0.023% |  |
| 1/25/2024 | Allspring Global Investments Holdings LLC | 11,827 | $0.16M | 0.0% | N/A | 0.083% |  |
| 11/15/2023 | Kennedy Capital Management LLC | 93,708 | $1.16M | 0.0% | +2.4% | 0.654% |  |
| 11/14/2023 | Wittenberg Investment Management Inc. | 209,739 | $2.59M | 0.9% | +2.3% | 1.465% |  |
| 11/8/2023 | Sepio Capital LP | 306,680 | $3.78M | 0.3% | +4.1% | 2.142% |  |
| 8/11/2023 | Wittenberg Investment Management Inc. | 204,994 | $2.52M | 0.9% | +3.5% | 1.432% |  |
| 8/4/2023 | American International Group Inc. | 5,039 | $62K | 0.0% | N/A | 0.035% |  |
| 8/3/2023 | Fifth Lane Capital LP | 10,929 | $0.13M | 0.0% | N/A | 0.077% |  |
| 5/15/2023 | Wittenberg Investment Management Inc. | 197,994 | $2.43M | 0.9% | +3.6% | 1.388% |  |
| 5/15/2023 | Madison Avenue Partners LP | 553,085 | $6.80M | 1.5% | N/A | 3.879% |  |
| 5/15/2023 | Sio Capital Management LLC | 272,843 | $3.35M | 1.7% | +9.1% | 1.913% |  |
| 5/12/2023 | Yakira Capital Management Inc. | 72,118 | $0.89M | 0.2% | -15.9% | 0.506% |  |
| 2/15/2023 | Nantahala Capital Management LLC | 210,000 | $2.41M | 0.2% | -51.1% | 1.566% |  |
| 2/10/2023 | 22NW LP | 1,015,048 | $11.63M | 6.3% | -17.5% | 7.569% |  |
| 2/10/2023 | Yakira Capital Management Inc. | 85,732 | $0.98M | 0.2% | -26.0% | 0.639% |  |
| 2/6/2023 | Wittenberg Investment Management Inc. | 191,194 | $2.19M | 0.9% | +1.3% | 1.426% |  |
| 11/14/2022 | Point72 Asset Management L.P. | 1,100,994 | $4.13M | 0.0% | +228.5% | 8.210% |  |
| 11/10/2022 | Nantahala Capital Management LLC | 429,596 | $1.61M | 0.1% | -12.6% | 3.204% |  |
| 10/28/2022 | Sepio Capital LP | 294,545 | $1.11M | 0.1% | -6.9% | 2.196% |  |
| 8/16/2022 | Western Standard LLC | 1,269,558 | $7.55M | 5.7% | +8.3% | 9.467% |  |
| 8/15/2022 | Nantahala Capital Management LLC | 491,509 | $2.92M | 0.1% | -4.9% | 3.665% |  |
| 8/11/2022 | Yakira Capital Management Inc. | 115,821 | $0.69M | 0.1% | +30.6% | 0.864% |  |
| 7/26/2022 | Sepio Capital LP | 316,313 | $1.88M | 0.2% | +6.7% | 2.359% |  |
| 5/13/2022 | Bronte Capital Management Pty Ltd. | 578,313 | $3.66M | 0.3% | +7.6% | 4.313% |  |
| 5/12/2022 | Yakira Capital Management Inc. | 88,683 | $0.56M | 0.1% | +20.7% | 0.661% |  |
| 5/9/2022 | Sepio Capital LP | 296,546 | $1.88M | 0.2% | +276.2% | 2.211% |  |
| 2/16/2022 | Western Standard LLC | 1,172,463 | $4.58M | 2.7% | -7.6% | 8.743% |  |
| 2/10/2022 | Bronte Capital Management Pty Ltd. | 537,584 | $2.10M | 0.1% | -2.1% | 4.009% |  |
| 2/9/2022 | Dimensional Fund Advisors LP | 488,687 | $1.91M | 0.0% | -2.1% | 3.644% |  |
| 2/9/2022 | Yakira Capital Management Inc. | 73,450 | $0.29M | 0.0% | +21.1% | 0.548% |  |
| 1/20/2022 | Radnor Capital Management LLC | 13,332 | $52K | 0.0% | N/A | 0.099% |  |
| 11/15/2021 | Dimensional Fund Advisors LP | 499,368 | $2.41M | 0.0% | -3.5% | 3.724% |  |
| 11/9/2021 | BlackRock Inc. | 211,051 | $1.02M | 0.0% | +12.8% | 1.574% |  |
Data available starting January 2016
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
Read More on Merrimack Pharmaceuticals
Today's Range
Now: $15.13
52 Week Range
Now: $15.13
Volume
N/A
Average Volume
396,929 shs
Market Capitalization
$223.77 million
P/E Ratio
1.09
Dividend Yield
N/A
Beta
1.45